$0.4281
0.0514.16%
At close: -
$0.4290
0.000900.21%
After Hours: Jan 31, 7:59 PM EDT
Tonix Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Tonix Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.23 | $-2.93 | 92.2 % |
Q2 | 2024-08-16 | $-19.28 | $-7.20 | -167.8 % |
Q1 | 2024-05-13 | $-5.76 | $-12.48 | 53.8 % |
Q4 | 2024-04-01 | $-27.52 | $-52.48 | 47.6 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $2.82M | $3.08M | -8.38 % |
Q2 | 2024-08-16 | $2.21M | $3.35M | -34.1 % |
Q1 | 2024-05-13 | $2.48M | $3.80M | -34.7 % |
Q4 | 2024-04-01 | $3.78M | $3.83M | -1.33 % |
Tonix Pharmaceuticals (TNXP) is scheduled to report earnings on March 31, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.23, which beat the estimate of $-2.93.
The Actual Revenue was $2.8M, which missed the estimate of $3.1M.
Browse earnings estimates, EPS, and revenue on all stocks.